Meijer, Inc., et al v. Bausch Health Companies Inc., et al
| MEIJER, INC., MEIJER DISTRIBUTION, INC. and DIRECT PURCHASER CLASS PLAINTIFFS |
| GLENN WAYNE MITCHELL |
| BAUSCH HEALTH COMPANIES INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., ASSERTIO THERAPEUTICS, INC., LUPIN PHARMACEUTICALS, INC. and LUPIN LTD. |
| 22-16249 |
| August 17, 2022 |
| U.S. Court of Appeals, Ninth Circuit |
| Antitrust |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 18, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Case terminated, opened in error. [12519684] (BY) [Entered: 08/18/2022 10:58 AM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL AND PRO SE APPELLANT. SEND MQ: No. The schedule is set as follows: Transcript ordered by 09/15/2022. Transcript due 10/14/2022. Appellant Glenn Wayne Mitchell opening brief due 11/21/2022. Appellees Assertio Therapeutics, Inc., Bausch Health Companies Inc., Direct Purchaser Class Plaintiffs, Lupin Ltd., Lupin Pharmaceuticals, Inc., Meijer Distribution, Inc., Meijer, Inc., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd. and Santarus, Inc. answering brief due 12/21/2022. Appellant's optional reply brief is due 21 days after service of the answering brief. [12519007] (RT) [Entered: 08/17/2022 02:08 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
